(Q33275402)

25 July 2017

title

Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma (English)

1 reference

25 July 2017

0 references

0 references

1 reference

1 reference

7

0 references

Veit Rohde

4

0 references

Reza Akhavan-Sigari

1

object named as

R Akhavan-Sigari

1 reference

25 July 2017

M Abili

2

1 reference

25 July 2017

M R Gaab

3

1 reference

25 July 2017

N Zafar

5

1 reference

25 July 2017

P Emami

6

1 reference

25 July 2017

language of work or name

1 reference

17 October 2014

1 reference

25 July 2017

1 reference

25 July 2017

volume

38

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

89-98; discussion 98-9

1 reference

c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Chordoma: natural history and results in 28 patients treated at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

New candidate chromosomal regions for chordoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Tyrosine kinase receptors as attractive targets of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Imatinib mesylate in chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Chordoma: incidence and survival patterns in the United States, 1973-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Expression of hepatocyte growth factor and c-MET in skull base chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Response to imatinib plus sirolimus in advanced chordoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

The met proto-oncogene receptor and lumen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

ErbB receptors: from oncogenes to targeted cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-014-0579-X

Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases

21 January 2018

1 reference

12 December 2020

Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence

1 reference

12 December 2020

Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma

1 reference

12 December 2020

Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells

1 reference

12 December 2020

Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.

1 reference

12 December 2020

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

12 December 2020

A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm).

1 reference

12 December 2020

Intralesional fibrous septum in chordoma: a clinicopathologic and immunohistochemical study of 122 lesions

1 reference

12 December 2020

Tissue microarray: a new technology for amplification of tissue resources

1 reference

12 December 2020

Expression of Met protein in thyroid tumours

1 reference

12 December 2020

Evolution and development of distinct cell lineages derived from somites

1 reference

12 December 2020

Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) status in chordoma.

1 reference

12 December 2020

10.1007/S10143-014-0579-X

Identifiers

DOI

1 reference

release_2sbezbuaazbbpfcxsgsjrcxgxy

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2sbezbuaazbbpfcxsgsjrcxgxy

24 November 2022

mapped directly with Wikidata item

1 reference